BDO.LiveSite.Deals.DealTypeM&A
BDO.LiveSite.Deals.IndustryLife Sciences
BDO has provided sell-side M&A advisory services to RApport Global, a specialist international regulatory consultancy, to support its sale to ELIQUENT Life Sciences (formerly Validant), a full-service life sciences regulatory consultancy which operates globally and is a portfolio company of GHO Capital Partners.
RApport is a specialist international regulatory consultancy providing support to the pharmaceutical, biotechnological, and medical device industries. The company's global solutions include strategic and technical guidance across development programs, regulatory submissions and post-market support.
"Ifty and Lorna have built a remarkable business and it has been a pleasure to help them begin the next phase of their journey. These two high-quality businesses joining forces to support their customers in navigating an increasingly complex regulatory landscape is an exciting prospect. We look forward to seeing the combined business going from strength-to-strength."
Rishi Verma, Director, BDO Life Sciences
RApport is a specialist international regulatory consultancy providing support to the pharmaceutical, biotechnological, and medical device industries. The company's global solutions include strategic and technical guidance across development programs, regulatory submissions and post-market support.
"Ifty and Lorna have built a remarkable business and it has been a pleasure to help them begin the next phase of their journey. These two high-quality businesses joining forces to support their customers in navigating an increasingly complex regulatory landscape is an exciting prospect. We look forward to seeing the combined business going from strength-to-strength."
Rishi Verma, Director, BDO Life Sciences